K Gecse

7.7k total citations · 1 hit paper
174 papers, 4.6k citations indexed

About

K Gecse is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, K Gecse has authored 174 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Genetics, 95 papers in Surgery and 75 papers in Epidemiology. Recurrent topics in K Gecse's work include Inflammatory Bowel Disease (123 papers), Microscopic Colitis (65 papers) and Diverticular Disease and Complications (41 papers). K Gecse is often cited by papers focused on Inflammatory Bowel Disease (123 papers), Microscopic Colitis (65 papers) and Diverticular Disease and Complications (41 papers). K Gecse collaborates with scholars based in Netherlands, United States and United Kingdom. K Gecse's co-authors include Geert D’Haens, Ailsa Hart, Mark Löwenberg, Johan Burisch, Alessandro Armuzzi, Paolo Gionchetti, Cord Langner, Jimmy K. Limdi, Florian Rieder and Marcus Harbord and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Annals of Surgery.

In The Last Decade

K Gecse

163 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders

2017 1.3k citations Johan Burisch, K Gecse et al. Journal of Crohn s and Colitis profile →

Peers

Countries citing papers authored by K Gecse

Since Specialization

Citations

This map shows the geographic impact of K Gecse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Gecse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Gecse more than expected).

Fields of papers citing papers by K Gecse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Gecse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Gecse. The network helps show where K Gecse may publish in the future.

Co-authorship network of co-authors of K Gecse

This figure shows the co-authorship network connecting the top 25 collaborators of K Gecse. A scholar is included among the top collaborators of K Gecse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Gecse. K Gecse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOP017 Infliximab induction fails to reach targets in Perianal Fistulizing Crohn’s Disease: first results from the ATLANTIC study 2025 ·Journal of Crohn s and Colitis ·(unknown), (unknown), (unknown), (unknown), Ron A. A. Mathôt, Geert D’Haens, K Gecse	0
2	Long‐term outcomes of ‘temporary’ defunctioning in patients with severe perianal Crohn's disease 2025 ·Colorectal Disease ·(unknown), A. Pronk, K Gecse, Roel Hompes, W. A. Bemelman, Christianne J. Buskens	2
3	Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn’s disease 2025 ·Therapeutic Advances in Gastroenterology ·Rotem Sigall Boneh, (unknown), Eytan Wine, (unknown), Tim G. J. de Meij, Mark Löwenberg, K Gecse, Nicolette Wierdsma, Joep P. M. Derikx, Wouter J. de Jonge, Geert D’Haens, Mohammed Ghiboub, Johan Van Limbergen	1
4	Diagnostic Accuracy of Intestinal Ultrasound in the Detection of Intra-Abdominal Complications in Crohn’s Disease: A Systematic Review and Meta-Analysis 2024 ·Journal of Crohn s and Colitis ·(unknown), F de Voogd, Nahid S.M. Montazeri, Faridi S. van Etten‐Jamaludin, Geert D’Haens, K Gecse	18
5	Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review 2024 ·Journal of Crohn s and Colitis ·(unknown), (unknown), Valérie Pittet, Peter Bossuyt, Jurij Hanžel, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, (unknown), Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, K Gecse, Naila Arebi	1
6	Classifying Inflammation on Intestinal Ultrasound Images and Cineloops－A Learning Curve Study 2024 ·Journal of Crohn s and Colitis ·(unknown), Martin G. Tolsgaard, K Gecse, Kerri L. Novak, Christy Boscardin, Mohamed Attauabi, Johan Burisch, Trine Boysen, Rune Wilkens	3
7	Early Intestinal Ultrasound Predicts Clinical and Endoscopic Treatment Response and Demonstrates Drug-Specific Kinetics in Moderate-to-Severe Ulcerative Colitis 2023 ·Inflammatory Bowel Diseases ·F de Voogd, Steven Bots, (unknown), (unknown), (unknown), Geert D’Haens, K Gecse	11
8	Development of a Core Outcome Set for Real-world Data in Inflammatory Bowel Disease: A European Crohn’s and Colitis Organisation [ECCO] Position Paper 2022 ·Journal of Crohn s and Colitis ·Jurij Hanžel, Peter Bossuyt, Valérie Pittet, Mark Samaan, Monika Tripathi, Wladyslawa Czuber‐Dochan, Johan Burisch, S. Leone, (unknown), Filip Baert, Uri Kopylov, Susanna Jäghult, Michel Adamina, Naila Arebi, K Gecse	9
9	Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls – a prospective cohort study 2022 ·Alimentary Pharmacology & Therapeutics ·(unknown), F de Voogd, Willem A. Bemelman, Roel Hompes, Geert D’Haens, Christianne J. Buskens, K Gecse	3
10	Intestinal Ultrasound to Assess Ulcerative Colitis Disease Activity in Children: External Validation and Comparison of 2 Intestinal Ultrasound Activity Indices 2022 ·Inflammatory Bowel Diseases ·(unknown), Rick R. van Rijn, (unknown), F de Voogd, Joost van Schuppen, Angelika Kindermann, Tim G. J. de Meij, Johan Van Limbergen, K Gecse, Geert D’Haens, Marc A. Benninga, Bart G.P. Koot	13
11	P603 INSPIRE: 6-month interim analysis from an observational post-marketing registry on the effectiveness and safety of darvadstrocel in patients with Crohn’s disease and complex perianal fistulas 2022 ·Journal of Crohn s and Colitis ·Oded Zmora, Daniel C. Baumgart, William A. Faubion, Marc Ferrante, K Gecse, Elisabeth Genestin, (unknown), Gary Hantsbarger, Chitra Karki, Phil Tozer, Julián Panés	9
12	Fibrosis and MAGNIFI-CD Activity Index at Magnetic Resonance Imaging to Predict Treatment Outcome in Perianal Fistulizing Crohn’s Disease Patients 2021 ·Journal of Crohn s and Colitis ·(unknown), EM Meima-van Praag, Patrick M. Bossuyt, Geert D’Haens, K Gecse, Karin Horsthuis, (unknown), Jeroen A. W. Tielbeek, Christianne J. Buskens, Jaap Stoker	35
13	Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm 2021 ·Journal of Crohn s and Colitis ·Steven Bots, F de Voogd, Menno D. de Jong, (unknown), Mark Löwenberg, Marjolijn Duijvestein, Cyriel Y. Ponsioen, G D’Haens, K Gecse	34
14	P823 DNA methylation profiles accurately predict vedolizumab response and remain stable during induction and maintenance treatment in Crohn’s disease 2020 ·Journal of Crohn s and Colitis ·V Joustra, (unknown), Annie Yim, K Gecse, Mark Löwenberg, Anje A. te Velde, Jack Satsangi, (unknown), Peter Henneman, Geert D’Haens	2
15	A Reliability Study: Strong Inter-Observer Agreement of an Expert Panel for Intestinal Ultrasound in Ulcerative Colitis 2020 ·Journal of Crohn s and Colitis ·F de Voogd, Rune Wilkens, K Gecse, Mariangela Allocca, Kerri L. Novak, Cathy Lu, Geert D’Haens, Christian Maaser	59
16	Systematic Review: Histological Scoring of Strictures in Crohn’s Disease 2020 ·Journal of Crohn s and Colitis ·F de Voogd, Aart Mookhoek, K Gecse, Gert De Hertogh, Willem A. Bemelman, Christianne J. Buskens, Geert D’Haens	12
17	Bowel ultrasound measurements in healthy children — systematic review and meta-analysis 2019 ·Pediatric Radiology ·(unknown), F de Voogd, Rick R. van Rijn, Johanna H. van der Lee, Merit M. Tabbers, Faridi S. van Etten‐Jamaludin, Angelika Kindermann, Tim G. J. de Meij, K Gecse, Geert D’Haens, Marc A. Benninga, Bart G.P. Koot	33
18	Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy 2018 ·Alimentary Pharmacology & Therapeutics ·Toer Stevens, (unknown), (unknown), Claire E Parker, Manon E. Wildenberg, K Gecse, Geert D’Haens	33
19	Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies 2017 ·Digestive and Liver Disease ·Lóránt Gönczi, Zsuzsanna Kürti, Petra A. Golovics, Barbara D. Lovász, (unknown), (unknown), (unknown), (unknown), Ákos Iliás, (unknown), K Gecse, (unknown), Waqqas Afif, Alain Bitton, Zsuzsanna Végh, Péter L. Lakatos	10
20	P295. Preliminary assessment of efficacy and safety of switching between originator and biosimilar infliximab in paediatric Crohn disease patients. 2015 ·Journal of Crohn s and Colitis ·Zsuzsanna Kürti, K Gecse, Anita Bálint, Klaudia Farkas, Barbara D. Lovász, András Szabó, M. Mandel, (unknown), Koloman Krištof, Zsuzsanna Végh, (unknown), Tamás Molnár, László Kiss, Petra A. Golovics, Péter L. Lakatos	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact